Salter Brothers Emerging Companies Ltd
ASX:SB2
Salter Brothers Emerging Companies Ltd
ASX:SB2
Price:
0.67
AUD
1.9%
Market Closed
Market Cap:
AU$56.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Salter Brothers Emerging Companies Ltd
ASX:SB2
|
AU |
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
KR |
|
Derichebourg SA
PAR:DBG
|
FR |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
APA Corp (US)
NASDAQ:APA
|
US |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
Income Statement
Earnings Waterfall
Salter Brothers Emerging Companies Ltd
Salter Brothers Emerging Companies Ltd
Income Statement
Salter Brothers Emerging Companies Ltd
Salter Brothers Emerging Companies Ltd
Currency: AUD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
(1)
N/A
|
(9)
-1 049%
|
8
N/A
|
22
+171%
|
7
-68%
|
(1)
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Operating Income |
(3)
N/A
|
(12)
-275%
|
6
N/A
|
19
+225%
|
4
-78%
|
(3)
N/A
|
|
| Pre-Tax Income | |||||||
| Pre-Tax Income |
(3)
N/A
|
(12)
-275%
|
6
N/A
|
19
+225%
|
4
-78%
|
(3)
N/A
|
|
| Net Income | |||||||
| Tax Provision |
1
|
4
|
(2)
|
(6)
|
(1)
|
1
|
|
| Income from Continuing Operations |
(2)
|
(8)
|
4
|
13
|
3
|
(2)
|
|
| Net Income (Common) |
(2)
N/A
|
(8)
-333%
|
4
N/A
|
13
+217%
|
3
-77%
|
(2)
N/A
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.09
-350%
|
0.05
N/A
|
0.15
+200%
|
0.04
-73%
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
